Evonik Invests US$220 Million in Partnership with the U.S. Government to Build New Lipid Production Facility for mRNA-Based Therapies in the U.S.
Important contribution to the development of new mRNA therapies beyond COVID-19 vaccines Tippecanoe site in Lafayette, Indiana, will enable flexible production of lipids The Biomedical Advanced Research and Development Authority… Read More




